The drugmaker’s blockbuster deal for Alexion marks a departure, but deserves the benefit of the doubt. A bidding war would complicate things.
The drugmaker’s blockbuster deal for Alexion marks a departure, but deserves the benefit of the doubt. A bidding war would complicate things.